EMA lisocabtagene maraleucel coverage for business development, investment, and market access teams
Earlier
High impact AnalysisApr 25, 2026
CAR-T Access EU Policy: Impact of Cross-Border Healthcare on Advanced Therapies
EMA · oncology · 10 min
Dr. Sarah MitchellHigh impact NewsApr 1, 2026
CHMP Positive Opinion CAR-T Therapy: What You Need to Know
CHMP (Committee for Medicinal Products for Human Use) · hematology · 7 min
Dr. Elena RossiPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- Press Releases 443 articles
- Oncology 443 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways